To compare Endoscopic guided fine needle aspiration biopsy versus endoscopic guided fine needle aspiration cytology for diagnosis of solid pancreatic lesio
Not Applicable
- Conditions
- Health Condition 1: C251- Malignant neoplasm of body of pancreasHealth Condition 2: C250- Malignant neoplasm of head of pancreasHealth Condition 3: C259- Malignant neoplasm of pancreas, unspecifiedHealth Condition 4: C252- Malignant neoplasm of tail of pancreasHealth Condition 5: K868- Other specified diseases of pancreas
- Registration Number
- CTRI/2022/11/047481
- Lead Sponsor
- PG Thesis Project AIIMS Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients presenting for EUS evaluation of solid pancreatic lesions.
2. Accidentally discovered solid pancreatic lesions during EUS examination for any other cause
3. In patients between 18-80 years there is a solid pancreatic lesion with ambiguous imaging findings in CT or MRI
Exclusion Criteria
1.Age under 18 years and more than 80 years
2.Small lesion with size <1cm on imaging
3.History of any prior gastric surgery or gastrectomy
4.Inability or refusal to provide informed consent.
5.Uncorrected Coagulopathy
6.Patients with cystic pancreatic lesions
7.Critically ill patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the diagnostic accuracy of EUS guided fine-needle biopsy (FNB) with EUS guided fine-needle aspiration cytology (FNAC) for tissue diagnosis in solid pancreatic lesionsTimepoint: 18 months
- Secondary Outcome Measures
Name Time Method 1.Proportion of patients with optimal histologic core present in EUS guided FNA & EUS guided FNB group (Histologic Core, tissue fragment, Histologic inadequacy) <br/ ><br>2. Cellularity scoring in patients in EUS guided FNA & EUS guided FNB ( Scant, Low, Moderate, High)Timepoint: 18 months